Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC]: Side Effects & Safety Data for 3 Drugs
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] includes 3 drugs with a combined 4,762 adverse event reports in the FDA FAERS database. Compare their safety profiles, side effects, and outcomes below.
3
Drugs in Class
4,762
Combined Reports
All Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] Drugs Ranked by Reports
| Drug | Brand Name | Reports | Deaths | Hosp. | Death Rate |
|---|---|---|---|---|---|
| IMIGLUCERASE | Cerezyme | 2,564 | 322 | 549 | 12.6% |
| VELAGLUCERASE ALFA | VPRIV | 1,745 | 229 | 771 | 13.1% |
| TALIGLUCERASE ALFA | ELELYSO | 453 | 48 | 92 | 10.6% |
Common Side Effects in Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] Drugs
| Side Effect | Reports | Deaths |
|---|---|---|
| Fatigue | 317 | 12 |
| Inappropriate schedule of product administration | 285 | 14 |
| Product dose omission issue | 278 | 17 |
| Pyrexia | 274 | 37 |
| Covid-19 | 250 | 16 |
| Malaise | 240 | 17 |
| Weight increased | 224 | 8 |
| Death | 209 | 209 |
| Fall | 205 | 21 |
| Arthralgia | 203 | 5 |